{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:43Z","timestamp":1791231583599,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ccl.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T16:09:15Z","timestamp":1570118955000},"page":"497-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Carcinoid Heart Disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Daniel","family":"Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ccl.2019.07.014_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"issue":"18","key":"10.1016\/j.ccl.2019.07.014_bib2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.014_bib3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.014_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","article-title":"Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities","volume":"77","author":"Lundin","year":"1988","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccl.2019.07.014_bib5","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management","volume":"90","author":"Fox","year":"2004","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.014_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000381930","article-title":"Carcinoid heart disease: from pathophysiology to treatment--'something in the way it moves'","volume":"101","author":"Grozinsky-Glasberg","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.014_bib7","first-page":"400","article-title":"Valvular disorders in carcinoid heart disease","volume":"31","author":"Yuan","year":"2016","journal-title":"Braz J Cardiovasc Surg"},{"issue":"20","key":"10.1016\/j.ccl.2019.07.014_bib8","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jacc.2015.05.086","article-title":"Carcinoid heart disease: the challenge of the unknown known","volume":"66","author":"Warner","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.014_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.014_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0735-1097(98)00354-4","article-title":"Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease","volume":"32","author":"Denney","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.ccl.2019.07.014_bib11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ccl.2019.07.014_bib12","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades","volume":"112","author":"Moller","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.014_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"20","key":"10.1016\/j.ccl.2019.07.014_bib14","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.108.776021","article-title":"Right-sided valve disease deserves a little more respect","volume":"119","author":"Bruce","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccl.2019.07.014_bib15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"Moller","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2019.07.014_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(85)90313-4","article-title":"The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease","volume":"79","author":"Ross","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccl.2019.07.014_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","article-title":"Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century","volume":"101","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2019.07.014_bib18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.ccl.2019.07.014_bib19","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor","volume":"27","author":"Korse","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.014_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-2143(99)90163-4","article-title":"Review of 10 years of the clinical use of brain natriuretic peptide in cardiology","volume":"134","author":"Valli","year":"1999","journal-title":"J\u00a0Lab Clin Med"},{"issue":"7","key":"10.1016\/j.ccl.2019.07.014_bib21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease","volume":"102","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2019.07.014_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrclinonc.2009.70","article-title":"A\u00a0stepwise approach to the management of metastatic midgut carcinoid tumor","volume":"6","author":"Bhattacharyya","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.014_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11936-013-0265-2","article-title":"Carcinoid valve disease","volume":"15","author":"Askew","year":"2013","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.ccl.2019.07.014_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.11226","article-title":"Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor","volume":"97","author":"Zuetenhorst","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.014_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya","year":"2011","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.014_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/ERC-14-0173","article-title":"Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide","volume":"21","author":"Kulke","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.014_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/jc.2014-2247","article-title":"Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial","volume":"100","author":"Pavel","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.014_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2016.69.2780","article-title":"Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome","volume":"35","author":"Kulke","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.014_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid heart disease","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"issue":"20","key":"10.1016\/j.ccl.2019.07.014_bib30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.014_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.014_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2044.1976.tb11796.x","article-title":"Carcinoid syndrome: its relevance to the anaesthetist","volume":"31","author":"Mason","year":"1976","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.014_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004311-199703540-00009","article-title":"Anesthesia for patients with carcinoid syndrome","volume":"35","author":"Vaughan","year":"1997","journal-title":"Int Anesthesiol Clin"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.014_bib34","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1213\/01.ane.0000284704.57806.0b","article-title":"Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases","volume":"105","author":"Weingarten","year":"2007","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.ccl.2019.07.014_bib35","first-page":"1046","article-title":"Transcatheter pulmonic valve replacement in carcinoid heart disease","volume":"16","author":"Heidecker","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.014_bib36","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.athoracsur.2010.04.101","article-title":"Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis","volume":"90","author":"Hon","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.014_bib37","first-page":"114","article-title":"Transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration in carcinoid heart disease","volume":"17","author":"Khan","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.014_bib38","first-page":"110","article-title":"Carcinoid heart valve disease: transcatheter pulmonary valve-in-valve implantation in failing biological xenografts","volume":"24","author":"Conradi","year":"2015","journal-title":"J\u00a0Heart Valve Dis"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865119300633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865119300633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:51:20Z","timestamp":1760007080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865119300633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0733865119300633"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2019.07.014","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinoid Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}